Tag: landscape

MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeking approval for an additional indication for MINJUVI® (tafasitamab) in combination with rituximab and lenalidomide for the treatment of adult patients with previously treated follicular lymphoma (FL). The supplemental application for the additional indication was selected for review under Project Orbis.

According to Towards Chemical and Materials, the global green building materials market volume was valued at 600 million tons in 2024 and is predicted to hit around 1,271.6 million tons by 2034 growing at a CAGR of 7.80% from 2025 to 2034. North America dominated the green building materials market with a market share of 31.14% in 2024.

Total Revenue Growth of 20% to $63.2 Million, with MACI Revenue Growth of 21% to $53.5 Million

Discover comprehensive insights with the "Hypocobalaminemia (Vitamin B12) Deficiency - Global Clinical Trials Review, 2025." This report covers the global landscape of Vitamin B12 deficiency trials, with detailed data by region, country, and phase. Optimize strategies with top-line analysis of trial trends and key opportunities.

Sales Revenues and Profitability

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY, OR CONSTITUTE A VIOLATION OF, THE RELEVANT LAWS OF THAT JURISDICTION OR REQUIRE EURONEXT AND/OR ATHEX TO TAKE ANY FURTHER ACTION.